Thirty-Days versus Longer Duration of Dual Antiplatelet Treatment after Percutaneous Coronary Interventions with Newer Drug-Eluting Stents: A Systematic Review and Meta-Analysis

Abbreviation of the duration of dual antiplatelet therapy (DAPT) (one or three months) has been recently proposed, especially for high bleeding risk patients, after percutaneous coronary intervention (PCI) with drug-eluting stent (DES). Three databases were screened for eligible randomized control t...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsigkas, Grigorios, Apostolos, Anastasios, Chlorogiannis, David-Dimitrios, Bousoula, Elena, Vasilagkos, Georgios, Tsalamandris, Sotirios, Tsiafoutis, Ioannis, Katsanos, Konstantinos, Toutouzas, Konstantinos, Aminian, Adel, Alexopoulos, Dimitrios, Davlouros, Periklis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056726/
https://www.ncbi.nlm.nih.gov/pubmed/36983821
http://dx.doi.org/10.3390/life13030666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056726/
https://www.ncbi.nlm.nih.gov/pubmed/36983821
http://dx.doi.org/10.3390/life13030666

Ejemplares similares